Screener / SEC EDGAR /CIK 0001818201 /Numbers from the XBRL of the 10-Ks
Nasdaq Technology · Software

CCC Intelligent Solutions Holdings Inc. CCC

Compare with peers Embed
The 10-K against last year's

111 changes: 22 added, 7 removed, 81 reworded, 1 quiet changes

10-K Feb 24, 2026 vs Feb 25, 2025

10-K 0001193125-26-067448 (Feb 24, 2026) vs 10-K 0000950170-25-026848 (Feb 25, 2025) Not compared: Legal Proceedings.

Every paragraph, and how much of it changed

One bar per paragraph, in the order of the 10-K. Height and colour show the share of its words not in the closest paragraph a year earlier; the tallest bars are new paragraphs.

Risk Factors

14 paragraphs · 0 new · 1 reworded · 0 gone · 10-K Feb 24, 2026 against Feb 25, 2025
New paragraph Reworded (5% of its words or more) Same or nearly
Paragraph 4 · 48% changed Every version of it
•the impact of factors outside of our control including public health outbreaks, epidemics or pandemics on our business natural catastrophes, war and results of operations; terrorism;

MD&A

175 paragraphs · 22 new · 88 reworded · 7 gone · 10-K Feb 24, 2026 against Feb 25, 2025
New paragraph Reworded (5% of its words or more) Same or nearly
Paragraph 136 · 50% changed
Amortization of intangible assets Net cash received related to the Swaps was $71.8 million and $72.0 $0.4 million for the years ended December 31, 2024 2025, recorded within other (expense) income-net on the consolidated statement of operations and 2023, respectively. comprehensive income (loss).
Paragraph 74 · 48% changed
Selling and marketing Interest expense increased by $1.4 $6.4 million to $142.2 $71.0 million, or 1.0%, 9.9%, for the year ended December 31, 2024, 2025, compared to the year ended December 31, 2023. 2024. The increase was primarily due to interest incurred on the Promissory Note Payable by CCC Cayman and its subsidiaries issued to a $6.3 minority investor in May 2025 and interest incurred on an additional $225.0 million increase term loan as part of the third amendment for the 2021 Credit Agreement, entered into in personnel-related costs, including sales incentives and travel costs, January 2025, partially offset by a $5.1 million decrease in stock-based compensation. lower variable interest rates during the year ended December 31, 2025, compared to the year ended December 31, 2024.
Paragraph 145 · 47% changed
Net cash used in financing activities was $323.0 million for the year ended December 31, 2023. Net cash used in financing activities was due to a $328.5 million repurchase of common stock, $16.7 million of payroll tax payments related to the net share settlement of employee equity awards, and $8.0 $10.0 million of principal payments of long-term debt, and $7.7 million of payments for fees associated with a debt payments, modifications, partially offset by $25.4 $525.0 million of incremental term loans used for the acquisition of EvolutionIQ and the Accelerated Share Repurchase program, $5.0 million of proceeds from the issuance of stock under the employee stock purchase plan, and $4.7 million of proceeds from stock options exercises and $4.8 million of proceeds from shares purchased through the Company's Employee Stock Purchase Plan. option exercises.
Paragraph 175 · 47% changed
Amortization of Goodwill and intangible assets recognized in connection with our acquisition of EvolutionIQ in January 2025 was $71.8 $537.8 million and $72.0 million for the years ended December 31, 2024 and 2023, $167.9 million, respectively.
Paragraph 37 · 42% changed
•Expansion of solution adoption from existing customers: A central part of our strategy is expanding solution adoption across our existing customer base. We have developed long-term relationships with our customers and have a proven track record of successfully cross-selling product offerings. We have the opportunity to realize incremental value by selling additional functionality to customers that do not currently utilize our full solution portfolio. As we innovate and bring new technology and solutions to market, we also have the opportunity to realize incremental value by selling new software solutions to our existing customer base. Capitalizing on this opportunity is a significant driver of our revenue growth and Software NDR.
Paragraph 105 · 40% changed
The proceeds of the 2021 Credit Agreement and — The 2021 Credit Agreement originally consisted of an $800.0 million term loan, the proceeds of which, with cash on hand were used to repay all outstanding borrowings under the Company’s previous credit agreement. The 2021 Credit Agreement also includes a revolving credit facility (“2021 Revolving Credit Facility”) for an aggregate principal amount of $250.0 million. The 2021 Revolving Credit Facility has a sublimit of $75.0 million for letters of credit.
Paragraph 69 · 39% changed
Gross profit increased by $63 million to $776.8 million, or 8.8%, for the year ended December 31, 2023. 2025, compared to the year ended December 31, 2024. Our gross profit margin increased was 73.5% for the year ended December 31, 2025 compared to 75.6% for the year ended December 31, 2024 compared to 73.4% for the year ended December 31, 2023. 2024. The increase in both gross profit and gross profit margin was primarily due to increased reflects higher software subscription revenues, revenues and enhanced economies of scale resulting from fixed cost arrangements and lower amortization of acquired technologies, arrangements, including contributions from the January 2025 EvolutionIQ acquisition. These factors were partially offset by the an increase in depreciation expense related to additional investments in new and enhanced customer solutions and platform development. cost of revenue.
Paragraph 48 · 38% changed
Our research and development expenses consist primarily of personnel-related costs, including stock-based compensation, and costs of external development resources involved in the engineering, design and development of new solutions, as well as expenses associated with significant ongoing improvements to existing solutions. Research and development expenses also include costs for certain IT expenses supporting development environments.

A paragraph is matched with the one last year that shares the most of its words; under half in common makes it new. The paragraphs shown are the 1 reworded the most in each section.

The paragraph that changed most in each section

The redline

Marked against last year's 10-K: cut words struck through, new words highlighted.

Accounting Policies150 words changed in this paragraph; it is 34% similar to last year's version.
In December 2023, Recently Issued Accounting Pronouncements—In September 2025, the FASB Financial Accounting Standards Board (“FASB”) issued ASU 2023-09, Income Taxes (Topic 740): Accounting Standards Update 2025-06, Intangibles-Goodwill and Other - Internal-Use Software (Subtopic 350-40): Targeted Improvements to Income Tax Disclosures. This the Accounting for Internal-Use Software. Among other things, this update removes the accounting consideration of software project development stages, and requires entities an entity to disclose disaggregated information about their effective tax rate reconciliation as well as expanded information on income taxes paid by jurisdiction. start capitalizing software costs when management has authorized and committed to funding the software project, and it is probable that the project will be completed and used to perform its intended function. The disclosure requirements will guidance can be applied on a prospective perspective basis, with the option to apply them retrospectively. modified basis, or retrospective basis. The amendments in this update are effective for fiscal years beginning after December 15, 2024, with early adoption permitted. 2027, and interim periods in those fiscal years. The Company is evaluating the disclosure requirements related impact of the adoption of ASU 2025-06 to this update. its consolidated financial statements.

Source: Item 8, Note 2 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES, 10-K 0001193125-26-067448 vs Item 8, Note 2 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES, 10-K 0000950170-25-026848

MD&A109 words changed in this paragraph; it is 38% similar to last year's version.
We believe that Adjusted Operating Income, as defined below, provides meaningful supplemental information regarding our performance by excluding certain items that may not be indicative of our recurring core business operating results. Adjusted Operating Income is defined as operating income (loss) adjusted for amortization, stock-based compensation expense and related employer payroll tax, costs associated with the acquisition and integration of completed and potential M&A, litigation costs in legal matters in which we are were the plaintiff and related antitrust matters, equity transaction and related costs, including secondary offering costs, debt refinancing costs, change in fair value of contingent consideration, consideration and goodwill and intangible asset impairment charges, lease abandonment charges, contract termination costs, lease overlap costs for the incremental expenses associated with the Company’s new corporate headquarters prior to termination of its then existing headquarters’ lease and income related to divestiture, net. charges.

Source: Item 7, 10-K 0001193125-26-067448 vs Item 7, 10-K 0000950170-25-026848

Risk Factors19 words changed in this paragraph; it is 42% similar to last year's version.
•the impact of factors outside of our control including public health outbreaks, epidemics or pandemics on our business natural catastrophes, war and results of operations; terrorism;

Source: Item 1A, 10-K 0001193125-26-067448 vs Item 1A, 10-K 0000950170-25-026848

Sentences and paragraphs added, removed or reworded

Every change, by type

Sentences and paragraphs of CCC's Risk Factors and MD&A, 10-K Feb 24, 2026 against 10-K Feb 25, 2025. Each links to the text at sec.gov.

Quiet changes are sentences kept from last year with one to four words changed, at least one of them a hedge, a modal or a qualifier (may, could, will, not, significant, material…). A year or date rolling forward is not counted.

The full word list

adverse, adversely, all, although, anticipate, anticipates, any, approximately, believe, believes, can, cannot, certain, could, expect, expects, generally, however, if, intend, intends, largely, likely, many, material, materially, may, might, most, must, never, no, not, possible, primarily, probable, should, significant, significantly, some, substantial, substantially, unlikely, will, would

AddedMD&A
Pursuant to the terms of the Fifth Amendment, the Company incurred incremental term loans in an aggregate principal amount $300.0 million, which were used to fund the Accelerated Share Repurchase (“ASR”) program.
Read it in 10-K Feb 24, 2026 at sec.gov
AddedMD&A
On December 12, 2025, the Company entered into an ASR with a third-party financial institution to repurchase $300.0 million of its common stock. At inception, the Company paid the financial institution $300.0 million using proceeds from the Fifth Amendment and cash on hand, and received an initial delivery of 33,240,998 shares, which were immediately retired. The shares received were equal to 80% of the prepayment amount based on the closing price of the common stock on December 11, 2025 of $7.22 per share. The Company expects to receive additional shares upon settlement of the ASR no later than June 30, 2026.
Read it in 10-K Feb 24, 2026 at sec.gov
AddedMD&A
international subsidiaries or other ecosystem solutions, such as parts suppliers and other automotive manufacturers, and excludes CCC casualty solutions which are largely usage and professional service based.
Read it in 10-K Feb 24, 2026 at sec.gov
AddedMD&A
Beginning with the quarter ended March 31, 2025, our Software NDR calculation includes EvolutionIQ’s software revenue. The new calculation is a result of the acquisition of EvolutionIQ and not the result of a change in the methodology applicable to our pre-acquisition business. The calculation of Software NDR as of and following the quarter ended March 31, 2025 is consistent with the methodology described above, using Software NDR on a combined company basis for the prior year annualized software revenue to determine annualized revenue growth, and, with respect to EvolutionIQ’s software revenue, excludes (a) changes in estimates related to the timing of one-time revenue and other revenue, including professional services, and (b) annualized software revenue for smaller customers with annualized software revenue below the threshold of $100,000 for carriers (with shops not applicable to the EvolutionIQ business).
Read it in 10-K Feb 24, 2026 at sec.gov
AddedMD&A
Beginning with the quarter ended March 31, 2025, our Software GDR calculation includes EvolutionIQ’s software revenue. The new calculation is a result of the acquisition of EvolutionIQ and not the result of a change in methodology applicable to our pre-acquisition business. The calculation of Software GDR as of and following the quarter ended March 31, 2025 is consistent with the methodology described above, using Software GDR on a combined company basis for the prior year annualized software revenue to determine annualized revenue growth, and, with respect to EvolutionIQ’s software revenue excludes (a) changes in estimates related to the timing of one-time revenue and other revenue, including professional services, and (b) annualized software revenue for smaller customers with annualized software revenue below the threshold of $100,000 for carriers (with shops not applicable to the EvolutionIQ business).
Read it in 10-K Feb 24, 2026 at sec.gov
AddedMD&A
and costs in legal matters in which we were the plaintiff and related antitrust matters, equity transaction and related costs, including secondary offering costs, debt refinancing costs, change in fair value of contingent consideration and goodwill and intangible asset impairment charges.
Read it in 10-K Feb 24, 2026 at sec.gov
AddedMD&A
At the time of entering into the 2021 Credit Agreement, the Company incurred $3.1 million in financing costs related to the 2021 Revolving Credit Facility. The Company incurred $0.7 million in financing costs related to the Second Amendment. These costs were recorded to a deferred financing fees asset account and are being amortized to interest expense over the term of the 2021 Revolving Credit Facility. As of December 31, 2025 and December 31, 2024, the deferred financing fees asset balance was $1.4 million and $1.7 million, respectively.
Read it in 10-K Feb 24, 2026 at sec.gov
Show the other 24
AddedMD&A
all term loans under the 2021 Credit Agreement was extended to January 23, 2032, (iii) the credit spread adjustment applicable to SOFR loans under the 2021 Credit Agreement was removed, and (iv) interest rate margin applicable to all term loans under the 2021 Credit Agreement was removed.
Read it in 10-K Feb 24, 2026 at sec.gov
AddedMD&A
Pursuant to the terms of the Fifth Amendment, the Company incurred incremental term loans in an aggregate principal amount $300.0 million, which were used to fund the ASR program (Note 19).
Read it in 10-K Feb 24, 2026 at sec.gov
RemovedMD&A
Year Ended December 31, Change (dollar amounts in thousands, except share and per share data) 2024 2023 $ % Revenues $ 944,800 $ 866,378 $ 78,422 9.1% Cost of revenues, exclusive of amortization and impairment of acquired technologies 221,997 203,324 18,673 9.2% Amortization of acquired technologies 9,000 26,464 (17,464) -66.0% Impairment of acquired technologies — 431 (431) NM Cost of revenues(1) 230,997 230,219 778 0.3% Gross profit 713,803 636,159 77,644 12.2% Operating expenses: Research and development(1) 201,493 173,106 28,387 16.4% Selling and marketing(1) 142,217 140,851 1,366 1.0% General and administrative(1) 218,220 191,844 26,376 13.7% Amortization of intangible assets 71,768 71,972 (204) -0.3% Impairment of goodwill — 77,405 (77,405) NM Impairment of intangible assets — 4,906 (4,906) NM Total operating expenses 633,698 660,084 (26,386) -4.0% Operating income (loss) 80,105 (23,925) 104,030 NM Other (expense) income—net: Interest expense (64,608) (63,577) (1,031) -1.6% Interest income 12,203 16,252 (4,049) -24.9% Change in fair value of warrant liabilities 14,378 (15,096) 29,474 NM Other income—net 2,236 1,799 437 24.3% Total other (expense) income—net (35,791) (60,622) 24,831 41.0% Pretax income (loss) 44,314 (84,547) 128,861 NM Income tax provision (13,074) (5,524) (7,550) -136.7% Net income (loss) including non-controlling interest $ 31,240 $ (90,071) $ 121,311 NM Less: accretion of redeemable non-controlling interest (5,095) (2,405) (2,690) -111.9% Net income (loss) attributable to CCC Intelligent Solutions Holdings Inc.'s Common Stockholders $ 26,145 $ (92,476) $ 118,621 NM Net income (loss) per share attributable to common stockholders: Basic $ 0.04 $ (0.15) Diluted $ 0.04 $ (0.15) Weighted-average shares used in computing net income (loss) per share attributable to common stockholders: Basic 610,761,424 617,889,384 Diluted 641,875,525 617,889,384
Read it in 10-K Feb 25, 2025 at sec.gov
RemovedMD&A
No impairment was recognized during the year ended December 31, 2024. Impairment of acquired technologies was $0.4 million for the year ended December 31, 2023 due to an impairment charge recognized as a result of lower forecasted earnings and cash flows for the Company’s China reporting unit. See Note 11 to the consolidated financial statements included elsewhere in the Annual Report on Form 10-K for additional information.
Read it in 10-K Feb 25, 2025 at sec.gov
RemovedMD&A
There was no impairment charge recognized during the year ended December 31, 2024. We recorded impairment charges of goodwill and intangible assets of $77.4 million and $4.9 million, respectively, for the year ended December 31, 2023. The impairment charges were the result of lower forecasted earnings and cash flows for the Company’s China reporting unit. See Note 11 to the consolidated financial statements included elsewhere in this Annual Report on Form 10-K for additional information.
Read it in 10-K Feb 25, 2025 at sec.gov
RemovedMD&A
In May 2023, the Company entered into Amendment No. 1 to the 2021 Credit Agreement (the “Amendment”) to establish SOFR as the benchmark rate for determining the applicable interest rate, replacing LIBOR. No other terms, including the amount of borrowings, required payments or maturity date, were changed as a result of the Amendment. The Company did not incur any significant costs associated with the Amendment.
Read it in 10-K Feb 25, 2025 at sec.gov
RemovedMD&A
(1) a base rate determined by reference to the highest of (a) the rate last quoted by the Wall Street Journal as the “prime rate,” (b) the federal funds effective rate plus 0.50%, (c) one-month LIBOR plus 1.00% and (d) with respect to the Term B Loan, 1.50% and with respect to the 2021 Revolving Credit Facility, 1.00%, or
Read it in 10-K Feb 25, 2025 at sec.gov
RemovedMD&A
We account for our Private Warrants in accordance with the guidance contained in ASC 815-40. The warrants do not meet the criteria for equity treatment, thus we classify the warrants as liabilities at their fair value and adjust the warrants to fair value at each reporting period. This liability is subject to re-measurement at each balance sheet date until the warrants are exercised or redeemed. Any change in fair value is recognized in our consolidated statements of operations and comprehensive income (loss). The fair value of the Private Warrants was determined using the Black-Scholes option pricing model.
Read it in 10-K Feb 25, 2025 at sec.gov
RewordedMD&A
Year ended December 31, (dollar amounts in thousands) 2025 2024 2023 2022 Net income (loss) $1,688 $31,240 $(90,071) $38,406 Interest expense 71,007 64,608 63,577 38,990 Interest income (4,882) (12,203) (16,252) (908) Income tax provision 19,841 13,074 5,524 11,456 Amortization of intangible assets 74,047 71,768 71,972 72,278 Amortization of acquired technologies—Cost of revenue 17,473 9,000 26,464 26,938 Depreciation and amortization related to software, equipment and property 8,727 8,774 8,577 10,161 Depreciation and amortization related to software, equipment and property—Cost of revenue 50,033 34,134 28,325 17,772 Stock-based compensation expense and related employer payroll tax 181,285 177,808 147,707 111,865 M&A and integration costs 8,831 9,193 3,372 1,772 Litigation costs (proceeds) costs, net (3,665) 4,455 5,068 894 Equity transaction costs, including secondary offering costs 724 1,938 2,031 1,330 Change in fair value of derivative instruments 8,386 5,233 5,743 Income from derivative instruments (1,811) (7,167) (6,460) Debt refinancing costs 4,359 — — Change in fair value of contingent consideration — (100) — (100) Change in fair value of warrant liabilities — (14,378) 15,096 (26,073) Change in fair value of derivative instruments 5,233 5,743 (5,663) Income from derivative instruments (7,167) (6,460) — Goodwill and intangible asset impairment charges — — 82,742 — Lease abandonment — — 6,137 Contract termination costs — — 3,248 Lease overlap costs — — 1,338 Gain on sale of cost method investment — — (3,587) Income related to divestiture, net — — (877) Adjusted EBITDA $436,043 $397,377 $353,415 $305,377 Adjusted EBITDA Margin 41% 42% 41% 39%
Read it in 10-K Feb 24, 2026 at sec.gov
RewordedMD&A
Year ended December 31, (dollar amounts in thousands) 2025 2024 2023 2022 Net income (loss) $ 1,688 $ 31,240 $ (90,071) $ 38,406 Amortization of intangible assets 74,047 71,768 71,972 72,278 Amortization of acquired technologies—Cost of revenue 17,473 9,000 26,464 26,938 Stock-based compensation expense and related employer payroll tax 181,285 177,808 147,707 111,865 M&A and integration costs 8,831 9,193 3,372 1,772 Litigation costs (proceeds) costs, net (3,665) 4,455 5,068 894 Equity transaction costs, including secondary offering costs 724 1,938 2,031 1,330 Change in fair value of derivative instruments 8,386 5,233 5,743 Debt refinancing costs 4,359 — — Change in fair value of contingent consideration — (100) — (100) Change in fair value of warrant liabilities — (14,378) 15,096 (26,073) Change in fair value of derivative instruments 5,233 5,743 (5,663) Goodwill and intangible asset impairment charges — — 82,742 — Lease abandonment — — 6,137 Contract termination costs — — 3,248 Lease overlap costs — — 1,338 Gain on sale of cost method investment — — (3,587) Income related to divestiture, net — — (877) Tax effect of adjustments (55,105) (58,086) (59,638) (51,495) Adjusted net income $ 238,023 $ 238,071 $ 210,486 $ 176,411 Adjusted net income per share attributable to common stockholders Basic $ 0.38 $ 0.39 $ 0.34 Diluted $ 0.29 Diluted 0.36 $ 0.37 $ 0.32 $ 0.27 Weighted average shares outstanding Basic 629,960,378 610,761,424 617,889,384 607,760,886 Diluted 659,585,375 641,875,525 651,587,360 642,841,596
Read it in 10-K Feb 24, 2026 at sec.gov
RewordedMD&A
Adjusted EBITDA is defined as net income (loss) adjusted for interest, taxes, amortization, depreciation, stock-based compensation expense and related employer payroll tax, costs associated with the acquisition and integration of completed and potential M&A, litigation (proceeds) costs, net and costs in legal matters in which we are the plaintiff and related antitrust matters, equity transaction and related costs, including secondary offering costs, change in fair value of derivative instruments, income from derivative instruments, debt refinancing costs, change in fair value of contingent consideration, change in fair value of warrant liabilities, change in fair value of derivative instruments, income from derivative instruments, goodwill and intangible asset impairment charges, lease abandonment charges, contract termination costs, lease overlap costs for the incremental expenses associated with the Company’s new corporate headquarters prior to termination of its then existing headquarters’ lease, gain on sale of cost method investment and income related to divestiture, net. charges.
Read it in 10-K Feb 24, 2026 at sec.gov
RewordedMD&A
Adjusted Operating Expenses is defined as operating expenses adjusted for amortization of intangible assets, stock-based compensation expense and related employer payroll tax, costs associated with the acquisition and integration of completed and potential mergers and acquisitions (“M&A”), litigation costs in legal matters in which we are the plaintiff and related antitrust matters, equity transaction and related costs, including secondary offering costs, change in fair value of contingent consideration, goodwill and intangible asset impairment charges, lease abandonment charges, lease overlap costs for the incremental expenses associated with the Company’s new corporate headquarters prior to termination of its then existing headquarters’ lease and income related to divestiture, net. proceeds (costs), net
Read it in 10-K Feb 24, 2026 at sec.gov
RewordedMD&A
Year ended December 31, (dollar amounts in thousands) 2025 2024 2023 2022 Operating income (loss) $80,105 $(23,925) $51,922 $ 93,842 $ 80,105 $ (23,925) Amortization of intangible assets 74,047 71,768 71,972 72,278 Amortization of acquired technologies—Cost of revenue 17,473 9,000 26,464 26,938 Stock-based compensation expense and related employer 181,285 177,808 147,707 111,865 payroll tax M&A and integration costs 8,831 9,193 3,372 1,772 Litigation costs (proceeds) costs, net (3,665) 4,455 5,068 894 Equity transaction costs, including secondary offering costs 724 1,938 2,031 1,330 Debt refinancing costs 4,359 — — Change in fair value of contingent consideration — (100) — (100) Goodwill and intangible asset impairment charges — — 82,742 — Lease abandonment — — 6,137 Contract termination costs — — 3,248 Lease overlap costs — — 1,338 Income related to divestiture, net — — (877) Adjusted operating income $354,167 $315,431 $276,745 $ 376,896 $ 354,167 $ 315,431
Read it in 10-K Feb 24, 2026 at sec.gov
RewordedMD&A
Adjusted Net Income is defined as net income (loss) adjusted for the after-tax effects of amortization, stock-based compensation expense and related employer payroll tax, costs associated with the acquisition and integration of completed and potential M&A, litigation (proceeds) costs, net and costs in legal matters in which we are the plaintiff and related antitrust matters, equity transaction and related costs, including secondary offering costs, change in fair value of derivative instruments, debt refinancing costs change in fair value of contingent consideration, change in fair value of warrant liabilities, change in fair value of derivative instruments, liabilities and goodwill and intangible asset impairment charges. lease abandonment charges, contract termination costs, lease overlap costs for the incremental expenses associated with the Company’s new corporate headquarters prior to termination of its then existing headquarters’ lease, gain on sale of cost method investment and income related to divestiture, net.
Read it in 10-K Feb 24, 2026 at sec.gov
RewordedMD&A
Year ended December 31, (dollar amounts in thousands) 2025 2024 2023 2022 Operating expenses $ 682,966 $ 633,698 $ 660,084 $ 516,587 Amortization of intangible assets (74,047) (71,768) (71,972) (72,278) Stock-based compensation expense and related (169,686) (167,865) (138,578) (105,775) employer payroll tax M&A and integration costs (8,831) (9,193) (3,372) (1,772) Litigation costs proceeds (costs), net 3,665 (4,455) (5,068) (894) Equity transaction costs, including secondary offering costs (724) (1,938) (2,031) (1,330) Debt refinancing costs (4,359) — — Change in fair value of contingent consideration — 100 — 100 Goodwill and intangible asset impairment charges — — (82,311) — Lease abandonment — — (6,137) Lease overlap costs — — (1,338) Income related to divestiture, net — — 877 Adjusted operating expenses $ 428,984 $ 378,579 $ 356,752 $ 328,040
Read it in 10-K Feb 24, 2026 at sec.gov
RewordedMD&A
Adjusted Operating Income is defined as operating income (loss) adjusted for amortization, stock-based compensation expense and related employer payroll tax, costs associated with the acquisition and integration of completed and potential M&A, litigation (proceeds) costs, net and costs in legal matters in which we are the plaintiff and related antitrust matters, equity transaction and related costs, including secondary offering costs, debt refinancing costs, change in fair value of contingent consideration, consideration and goodwill and intangible asset impairment charges, lease abandonment charges, contract termination costs, lease overlap costs for the incremental expenses associated with the Company’s new corporate headquarters prior to termination of its then existing headquarters’ lease and income related to divestiture, net. charges.
Read it in 10-K Feb 24, 2026 at sec.gov
RewordedMD&A
Pursuant to the terms of the Fourth Amendment, (i) the Company incurred incremental term loans in an aggregate principal amount of $225 $225.0 million, which were used to (i) refinance certain outstanding incremental term loans (including the Incremental Term Loan), Loans), (ii) extend the maturity of all term loans to January 23, 2032, (iii) remove the credit spread adjustment applicable to SOFR loans, and (iv) reduce the interest rate margin applicable to all term loans to the following rate:
Read it in 10-K Feb 24, 2026 at sec.gov
RewordedMD&A
The increase was primarily due to a $21.7 $46.1 million increase in personnel-related costs, including a $9.9 million increase in stock-based compensation, primarily due to the acquisition of EvolutionIQ in January 2025, partially offset by a $6.2 $10.0 million increase decrease in IT related costs, and a $3.3 $9.2 million decrease increase in the amount of capitalized time on new and enhanced customer solutions and platform development, partially offset by and a $1.9 $0.8 million decrease in consulting and professional service costs.
Read it in 10-K Feb 24, 2026 at sec.gov
RewordedMD&A
Pursuant to the terms of the Fourth Amendment, (i) the Company incurred incremental term loans in an aggregate principal amount of $225 million, which were used to (i) refinance certain outstanding incremental term loans (including the Incremental Term Loan), (ii) extend the maturity of all term loans under the 2021 Credit Agreement was extended to January 23, 2032, (iii) remove the credit spread adjustment applicable to SOFR loans, Secured Overnight Financing Rate (“SOFR”) loans under the 2021 Credit Agreement was removed, and (iv) reduce the interest rate margin applicable to all term loans to under the following rate: 2021 Credit Agreement was removed.
Read it in 10-K Feb 24, 2026 at sec.gov
RewordedMD&A
Other than the business acquisition discussed in the “Recent Developments” section of this Management’s Discussion and Analysis of Financial Condition and Results of Operations, which has closed and for which payment has been completed, we We are not currently a party to any material definitive agreement regarding potential investments in, or acquisitions of, complementary business, applications or technologies.
Read it in 10-K Feb 24, 2026 at sec.gov

Sources

The two latest 10-Ks on EDGAR, section by section. Each change links to the text at sec.gov.

Also

New risk factors: paragraphs with nothing like them last year, quoted in full.

Work with it

Excel workbook · CSV. Google Sheet that stays up to date: paste =IMPORTDATA("https://tickdelta.com/company/CCC/export.csv") into a cell.

Next:Related parties
Esc

Type a ticker such as AAPL, a name, an investor such as Buffett, or a topic such as tariffs. ↑ ↓ to move, Enter to open.